On May 07, 2026, GENI reported earnings of -0.19 USD per share (EPS) for Q1 26, missing the estimate of -0.07 USD, resulting in a -169.28% surprise. Revenue reached 187.95 million, compared to an expected 174.02 million, with a 8.00% difference. The market reacted with a +8.64% price change (close before vs. close after earnings).
Looking ahead to Q2 26, 13 analysts forecast an EPS of -0.06 USD, with revenue projected to reach 178.62 million USD, implying an decrease of -68.42% EPS, and decrease of -4.97% in Revenue from the last quarter.